Exposure, Safety and Local Tolerance Study Comparing 3 Routes of Methotrexate (MTX) Administration: Vibex-MTX Device, Subcutaneous (SC)and Intramuscular (IM) in Adult Subjects With Rheumatoid Arthritis

Trial Profile

Exposure, Safety and Local Tolerance Study Comparing 3 Routes of Methotrexate (MTX) Administration: Vibex-MTX Device, Subcutaneous (SC)and Intramuscular (IM) in Adult Subjects With Rheumatoid Arthritis

Completed
Phase of Trial: Phase I/II

Latest Information Update: 23 Apr 2014

At a glance

  • Drugs Methotrexate (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Antares Pharma
  • Most Recent Events

    • 05 Aug 2011 The primary endpoints were met with all methods of adminstration, according to an Antares Pharma media release.
    • 05 Aug 2011 Results have been reported in an Antares Pharma media release.
    • 05 Aug 2011 Status changed from recruiting to completed, based on reporting of results in an Antares Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top